Group-based randomized trial of contingencies for health and abstinence in HIV patients.

Journal of Consulting and Clinical Psychology
Nancy M PetryKevin Dieckhaus

Abstract

Contingency management (CM) treatments are usually applied individually for drug abstinence, but CM can also be targeted toward health behaviors and implemented in groups. This study evaluated effects of a group-based CM intervention that focused on reinforcing health behaviors. HIV-positive patients with cocaine or opioid use disorders (n = 170) were randomized to weekly CM or 12-step (TS) groups for 24 weeks (mean attendance was 10.8 +/- 8.1 sessions for CM participants and 9.0 +/- 6.9 session for TS participants). During the treatment period, both groups received compensation for attendance ($10 per session) and submission of urine samples (about $2 per sample). In addition, participants received $25 for submitting samples and completing evaluations at Months 1, 3, 6, 9, and 12; 65-75 of the 81 participants assigned to TS and 71-80 of the 89 participants assigned to CM completed these evaluations. During the treatment period, patients in the CM group received chances to win prizes contingent upon completing health activities and submitting substance-free specimens (M = $260, SD = $267). Mean attendance was 10.8 +/- 8.1 sessions for CM participants and 9.0 +/- 6.9 sessions for TS participants. CM participants submitted a sign...Continue Reading

References

Nov 1, 1986·General Hospital Psychiatry·D L WolcottR T Mitsuyasu
Jul 1, 1985·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Oct 1, 1983·The Journal of Nervous and Mental Disease·T R KostenH D Kleber
Jul 1, 1994·Archives of General Psychiatry·S T HigginsG J Badger
Jan 1, 1993·Health Affairs·V MorS M Allen
Jun 1, 1997·Journal of Consulting and Clinical Psychology·M Y IguchiS D Husband
Oct 24, 1997·Journal of Consulting and Clinical Psychology·W K BickelR A Esch
Mar 11, 2000·Journal of Consulting and Clinical Psychology·S T HigginsR L Dantona
Mar 15, 2000·Journal of Substance Abuse Treatment·C LeonhardM Shwartz
Apr 26, 2000·Journal of Consulting and Clinical Psychology·N M PetryH R Kranzler
Jun 27, 2000·Journal of Substance Abuse Treatment·J L Kelley, N M Petry
Sep 7, 2000·Experimental and Clinical Psychopharmacology·S T HigginsA J Budney
Mar 10, 2001·Journal of Substance Abuse Treatment·N M PetryB Martin
Sep 12, 2001·Journal of Substance Abuse Treatment·N M PetryC Finocche
Sep 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·G B BovassoT G Cook
Jun 6, 2002·Journal of General Internal Medicine·Julia H ArnstenEllie E Schoenbaum
May 15, 2003·Addiction Biology·Maria Jose MiguezXimena Burbano
Oct 15, 2003·Archives of General Psychiatry·Stephen T HigginsStacey Anthony
Jan 17, 2004·Drug and Alcohol Dependence·Vera EhrensteinJeffrey H Samet
Jul 1, 2004·American Journal of Public Health·Mardge H CohenTracey E Wilson
Mar 31, 2005·Journal of Consulting and Clinical Psychology·Nancy M PetryFrancis Simcic
Nov 29, 2005·Journal of Substance Abuse Treatment·Stacey C Sigmon, Maxine L Stitzer
Dec 27, 2005·Drug and Alcohol Dependence·Nancy M PetryJohn A Hamilton
Jan 6, 2006·Journal of Consulting and Clinical Psychology·Nancy M PetryMichelle Tardif
Feb 1, 2006·Addiction·Jennifer Plebani LussierStephen T Higgins
Feb 1, 2007·AIDS Patient Care and STDs·Marc I RosenBruce Rounsaville
Jun 15, 2007·Experimental and Clinical Psychopharmacology·Sheila M AlessiNancy M Petry
Dec 19, 2007·Journal of Consulting and Clinical Psychology·Nancy M PetrySean Sierra

❮ Previous
Next ❯

Citations

Jul 5, 2012·AIDS and Behavior·Audrey PettiforMolly Rosenberg
Sep 1, 2012·Current HIV/AIDS Reports·Meredith Camp BinfordFrederick L Altice
Mar 30, 2011·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Nancy M PetryDanielle Barry
Jun 29, 2011·Experimental and Clinical Psychopharmacology·Nancy M Petry, John M Roll
Mar 26, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeffrey D FisherErin M Lenz
Oct 13, 2012·AIDS Research and Therapy·Marc I RosenUNKNOWN MACH14 Study Group
Feb 21, 2013·Experimental and Clinical Psychopharmacology·Steven E Meredith, Jesse Dallery
Mar 19, 2011·Drug and Alcohol Dependence·Steven E MeredithJesse Dallery
Oct 11, 2012·Pharmacology, Biochemistry, and Behavior·J Adam BennettCraig R Rush
Aug 6, 2016·Journal of Substance Abuse Treatment·Carla J RashNancy M Petry
Sep 30, 2016·The Cochrane Database of Systematic Reviews·Silvia MinozziLaura Amato
Nov 28, 2017·Current Opinion in Infectious Diseases·E Jennifer EdelmanBrandon D L Marshall
Jun 15, 2017·AIDS and Behavior·Bryan HartzlerDennis M Donovan
Oct 22, 2020·International Journal of Environmental Research and Public Health·Alireza BolooriJudith E Arnetz
Jun 24, 2018·The Medical Clinics of North America·E Jennifer EdelmanJeanette M Tetrault
Jun 23, 2021·Substance Abuse Treatment, Prevention, and Policy·Gabriela LópezJennifer E Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.